Literature DB >> 33363210

Proteomics of Colorectal Cancer: Tumors, Organoids, and Cell Cultures-A Minireview.

Philip H Lindhorst1, Amanda B Hummon1,2.   

Abstract

Proteomics, the study of the complete protein composition of a sample, is an important field for cancer research. Changes in the proteome can serve as a biomarker of cancer or lead to the development of a targeted therapy. This minireview will focus on mass spectrometry-based proteomics studies applied specifically to colorectal cancer, particularly the variety of cancer model systems used, including tumor samples, two-dimensional (2D) and three-dimensional (3D) cell cultures such as spheroids and organoids. A thorough discussion of the application of these systems will accompany the review of the literature, as each provides distinct advantages and disadvantages for colorectal cancer research. Finally, we provide conclusions and future perspectives for the application of these model systems to cancer research as a whole.
Copyright © 2020 Lindhorst and Hummon.

Entities:  

Keywords:  biomarkers; cell culture; colorectal cancer; mass spectrometry; organoids; proteomics; tumors

Year:  2020        PMID: 33363210      PMCID: PMC7758474          DOI: 10.3389/fmolb.2020.604492

Source DB:  PubMed          Journal:  Front Mol Biosci        ISSN: 2296-889X


  69 in total

1.  A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.

Authors:  Damien Besson; Aude-Hélène Pavageau; Isabelle Valo; Anthony Bourreau; Audrey Bélanger; Caroline Eymerit-Morin; Alice Moulière; Agnès Chassevent; Michelle Boisdron-Celle; Alain Morel; Jerôme Solassol; Mario Campone; Erick Gamelin; Benjamin Barré; Olivier Coqueret; Catherine Guette
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

2.  Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.

Authors:  Jing Wang; Dmitri Mouradov; Xiaojing Wang; Robert N Jorissen; Matthew C Chambers; Lisa J Zimmerman; Suhas Vasaikar; Christopher G Love; Shan Li; Kym Lowes; Karl-Johan Leuchowius; Helene Jousset; Janet Weinstock; Christopher Yau; John Mariadason; Zhiao Shi; Yuguang Ban; Xi Chen; Robert J C Coffey; Robbert J C Slebos; Antony W Burgess; Daniel C Liebler; Bing Zhang; Oliver M Sieber
Journal:  Gastroenterology       Date:  2017-06-16       Impact factor: 22.682

3.  Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.

Authors:  Jaco C Knol; Meike de Wit; Jakob Albrethsen; Sander R Piersma; Thang V Pham; Sandra Mongera; Beatriz Carvalho; Remond J A Fijneman; Gerrit A Meijer; Connie R Jiménez
Journal:  Biochim Biophys Acta       Date:  2013-12-17

Review 4.  Organoids in cancer research.

Authors:  Jarno Drost; Hans Clevers
Journal:  Nat Rev Cancer       Date:  2018-07       Impact factor: 60.716

Review 5.  Modeling Development and Disease with Organoids.

Authors:  Hans Clevers
Journal:  Cell       Date:  2016-06-16       Impact factor: 41.582

6.  MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.

Authors:  Fabio Bozzi; Angela Mogavero; Luca Varinelli; Antonino Belfiore; Giacomo Manenti; Claudio Caccia; Chiara C Volpi; Galina V Beznoussenko; Massimo Milione; Valerio Leoni; Annunziata Gloghini; Alexandre A Mironov; Ermanno Leo; Silvana Pilotti; Marco A Pierotti; Italia Bongarzone; Manuela Gariboldi
Journal:  J Exp Clin Cancer Res       Date:  2017-01-23

7.  Integrative multi-omics analysis of intestinal organoid differentiation.

Authors:  Rik Gh Lindeboom; Lisa van Voorthuijsen; Koen C Oost; Maria J Rodríguez-Colman; Maria V Luna-Velez; Cristina Furlan; Floriane Baraille; Pascal Wtc Jansen; Agnès Ribeiro; Boudewijn Mt Burgering; Hugo J Snippert; Michiel Vermeulen
Journal:  Mol Syst Biol       Date:  2018-06-26       Impact factor: 11.429

8.  Human colon organoids reveal distinct physiologic and oncogenic Wnt responses.

Authors:  Birgitta E Michels; Mohammed H Mosa; Britta M Grebbin; Diego Yepes; Tahmineh Darvishi; Johannes Hausmann; Henning Urlaub; Stefan Zeuzem; Hans M Kvasnicka; Thomas Oellerich; Henner F Farin
Journal:  J Exp Med       Date:  2019-02-21       Impact factor: 14.307

9.  Proteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells.

Authors:  Ugo Ala; Marta Manco; Giorgia Mandili; Emanuela Tolosano; Francesco Novelli; Paolo Provero; Fiorella Altruda; Sharmila Fagoonee
Journal:  Int J Mol Sci       Date:  2020-01-16       Impact factor: 5.923

Review 10.  Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research.

Authors:  Bruno Augusto Alves Martins; Gabriel Fonseca de Bulhões; Igor Norat Cavalcanti; Mickaella Michelson Martins; Paulo Gonçalves de Oliveira; Aline Maria Araújo Martins
Journal:  Front Oncol       Date:  2019-11-27       Impact factor: 6.244

View more
  4 in total

Review 1.  Metabolomics-based mass spectrometry methods to analyze the chemical content of 3D organoid models.

Authors:  Shannon E Murphy; Jonathan V Sweedler
Journal:  Analyst       Date:  2022-06-27       Impact factor: 5.227

2.  Bottom-Up Approach to the Discovery of Clinically Relevant Biomarker Genes: The Case of Colorectal Cancer.

Authors:  Faddy Kamel; Nathalie Schneider; Pasha Nisar; Mikhail Soloviev
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

3.  Down-regulated C4orf19 confers poor prognosis in colon adenocarcinoma identified by gene co-expression network.

Authors:  Wanpeng Wang; Xiaolu Lin; Ran Yu; Suqin Zhou; Yanyan Liu; Haifeng Jia; Feng Han; Yanzhi Bu; Juan Pu
Journal:  J Cancer       Date:  2022-01-09       Impact factor: 4.207

4.  Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.

Authors:  Maja Ludvigsen; Louise Thorlacius-Ussing; Henrik Vorum; Mogens Tornby Stender; Ole Thorlacius-Ussing; Bent Honoré
Journal:  Curr Issues Mol Biol       Date:  2021-09-02       Impact factor: 2.976

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.